Page 2 - அள்ளிஅன்சர்ஸ் வால்க்ரீன்ஸ் ப்ரைம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
AllianceRx Walgreens Prime, Highmark launch Social Determinants of Health Pilot
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Highmark, AllianceRx Walgreens Prime in social determinants of health pilot
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
AllianceRx Walgreens Prime, Highmark launch Social Determinants of Health Pilot
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Click here to subscribe to the Multiple Sclerosis News Today Newsletter! 4.5 (2)
Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference.
Women with multiple sclerosis (MS) who continue taking disease-modifying therapies (DMTs) throughout pregnancy accrue lower non-maternity healthcare costs related to hospitalization, new research shows.
Overall, the adjusted medical costs for patients who were consistently taking all of their medications were lowered by as much as $4,383, an analysis found.
According to the National MS Society, no DMTs are currently approved for use during pregnancy however, stopping treatment can increase the risk of relapses and associated health problems for people with MS.
Senior Editor
Women with MS who continue their disease-modifying therapy, or DMT, throughout pregnancy have lower hospitalization costs and use, compared to those who discontinued their therapy.
That finding comes from a retrospective study conducted by Walgreens in collaboration with AllianceRx Walgreens Prime to understand how non-adherence to these women’s DMTs would impact healthcare cost and utilization over a two-year period. The researchers presented the findings on Feb. 26 at the virtual Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2021.
MS is a chronic condition affecting the central nervous system that affects roughly 2.3 million people worldwide, with women affected two to three times as often as men. According to the National MS Society, none of the DMTs are approved for use during pregnancy yet discontinuing DMTs may cause relapse of disease. However, for certain DMTs, studies do indicate that some patients continue thei